| Issue Date | Title | Author(s) |
| 2016-05-01 | The Adaptation, Face, and Content Validation of a Needs Assessment Tool: Progressive Disease for People with Interstitial Lung Disease | Boland, JW; Reigada, C; Yorke, J; Hart, SP; Bajwah, S; Ross, J; Wells, A; Papadopoulos, A; Currow, DC; Grande, G; Macleod, U; Johnson, MJ |
| 2021-01-01 | Delirium management by palliative medicine specialists: a survey from the association for palliative medicine of Great Britain and Ireland. | Boland, JW; Kabir, M; Bush, SH; Spiller, JA; Johnson, MJ; Agar, M; Lawlor, P |
| 2017-11-01 | Effect of Opioids and Benzodiazepines on Clinical Outcomes in Patients Receiving Palliative Care: An Exploratory Analysis | Boland, JW; Allgar, V; Boland, EG; Oviasu, O; Agar, M; Currow, DC; Johnson, MJ |
| 2018-04-01 | The impact of therapeutic opioid agonists on driving-related psychomotor skills assessed by a driving simulator or an on-road driving task: A systematic review | Ferreira, DH; Boland, JW; Phillips, JL; Lam, L; Currow, DC |
| 2017-11-01 | Implementation of the Needs Assessment Tool for patients with interstitial lung disease (NAT:ILD): Facilitators and barriers | Reigada, C; Papadopoulos, A; Boland, JW; Yorke, J; Ross, J; Currow, DC; Hart, S; Bajwah, S; Grande, G; Wells, A; Johnson, MJ |
| 2017-03-01 | O-3 Opioids, benzodiazepines, anti-cholinergic load and clinical outcomes in patients with advanced cancer | Boland, JW; Allgar, V; Boland, EG; Oviasu, O; Agar, M; Currow, DC; Johnson, MJ |
| 2021-12 | Outcomes and measures of delirium interventional studies in palliative care to inform a core outcome set: A systematic review. | Agar, MR; Siddiqi, N; Hosie, A; Boland, JW; Johnson, MJ; Featherstone, I; Lawlor, PG; Bush, SH; Page, V; Amgarth-Duff, I; Garcia, M; Disalvo, D; Rose, L; Del-COrS Group, |
| 2020-09 | Patients' and caregivers' experiences of driving with chronic breathlessness before and after regular low-dose sustained-release morphine: A qualitative study. | Ferreira, DH; Boland, JW; Kochovska, S; Honson, A; Phillips, JL; Currow, DC |
| 2022-04-10 | Pharmacovigilance in hospice/palliative care: Net effect of amitriptyline or nortriptyline on neuropathic pain: UTS/IMPACCT Rapid programme international consecutive cohort. | Hussein, A; Digges, M; Chang, S; Hunt, J; Doogue, M; Rowett, D; Agar, M; Sinnarajah, A; Kain, D; Allan, S; Boland, JW; Currow, DC |
| 2018-01-01 | Pharmacovigilance in Hospice/Palliative Care: Net Effect of Haloperidol for Nausea or Vomiting | Digges, M; Hussein, A; Wilcock, A; Crawford, GB; Boland, JW; Agar, MR; Sinnarajah, A; Currow, DC; Johnson, MJ |
| 2021-12-20 | Risk factors for delirium in adult patients receiving specialist palliative care: A systematic review and meta-analysis. | Featherstone, I; Sheldon, T; Johnson, M; Woodhouse, R; Boland, JW; Hosie, A; Lawlor, P; Russell, G; Bush, S; Siddiqi, N |
| 2016-12-01 | Somatostatin Analogues Compared With Placebo and Other Pharmacologic Agents in the Management of Symptoms of Inoperable Malignant Bowel Obstruction: A Systematic Review | Obita, GP; Boland, EG; Currow, DC; Johnson, MJ; Boland, JW |
| 2022-06 | Symptom burden and lived experiences of patients, caregivers and healthcare professionals on the management of malignant bowel obstruction: A qualitative systematic review. | Baddeley, E; Mann, M; Bravington, A; Johnson, MJ; Currow, D; Murtagh, FEM; Boland, EG; Obita, G; Oliver, A; Seddon, K; Nelson, A; Boland, JW; Noble, SIR |
| 2022-10 | The range and suitability of outcome measures used in the assessment of palliative treatment for inoperable malignant bowel obstruction: A systematic review. | Bravington, A; Obita, G; Baddeley, E; Johnson, MJ; Murtagh, FE; Currow, DC; Boland, EG; Nelson, A; Seddon, K; Oliver, A; Noble, SI; Boland, JW |
